Self-Identification of Generic Drug Facilities, Sites and Organizations
Fiscal year 2018 reporting period for self-identification opens May 1st to June 1st of 2017
On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.
Fiscal year 2018 reporting period for self-identification opens May 1st to June 1st of 2017